Review
Published on 21 Sep 2022
The controversy of klotho as a potential biomarker in chronic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.931746
- 9,412 views
- 27 citations
Type at least 3 characters
604 articles
Articles
Systematic Review
Published on 16 Sep 2022
Risk of infection in roxadustat treatment for anemia in patients with chronic kidney disease: A systematic review with meta-analysis and trial sequential analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.967532
- 3,698 views
- 3 citations
Systematic Review
Published on 16 Sep 2022
Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.967317
- 5,816 views
- 8 citations
Review
Published on 15 Sep 2022
Sepsis-induced AKI: From pathogenesis to therapeutic approaches
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.981578
- 28,057 views
- 39 citations
Original Research
Published on 14 Sep 2022
Bibliometric and visual analysis of nephrotoxicity research worldwide
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.940791
- 4,282 views
- 10 citations
Original Research
Published on 14 Sep 2022
Efficacy and safety of tailin formulation combined with continuous low-dose antibiotic therapy in patients with recurrent urinary tract infection: A multicenter, randomized, controlled clinical trial
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.968980
- 1,969 views
- 2 citations
Review
Published on 13 Sep 2022
Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.969930
- 5,461 views
- 22 citations
Original Research
Published on 12 Sep 2022
SIRT6 overexpression retards renal interstitial fibrosis through targeting HIPK2 in chronic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1007168
- 4,057 views
- 16 citations
Review
Published on 12 Sep 2022
Emerging role of extracellular vesicles in kidney diseases
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.985030
- 3,181 views
- 5 citations
Original Research
Published on 08 Sep 2022
Calcium dobesilate efficiency in the treatment of diabetic kidney disease through suppressing MAPK and chemokine signaling pathways based on clinical evaluation and network pharmacology
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.850167
- 4,487 views
- 6 citations
Original Research
Published on 08 Sep 2022
Evaluation of the combination effect of rutin and vitamin C supplementation on the oxidative stress and inflammation in hemodialysis patients
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.961590
- 6,307 views
- 12 citations
Editorial
Published on 07 Sep 2022
Editorial: Insights in renal pharmacology: 2021
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1010691
- 2,066 views
Editorial
Published on 07 Sep 2022
Editorial: The gut-kidney axis: A potential drug target for treating kidney diseases
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1012890
- 1,566 views
- 2 citations
Original Research
Published on 06 Sep 2022
Paeoniflorin directly binds to TNFR1 to regulate podocyte necroptosis in diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.966645
- 6,169 views
- 17 citations
Review
Published on 02 Sep 2022
Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.970601
- 6,783 views
- 9 citations
Original Research
Published on 02 Sep 2022
Therapeutic effects and mechanisms of N-(9,10-anthraquinone-2-ylcarbonyl) xanthine oxidase inhibitors on hyperuricemia
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.950699
- 5,566 views
- 10 citations